Skip to main content
. 2015 Mar 13;4(7):1060–1068. doi: 10.1002/cam4.449

Figure 2.

Figure 2

Serum pharmacokinetics of interleukin-13-Pseudomonas exotoxin (IL-13-PE) for each patient enrolled. Only serum samples with IL-13-PE concentration above the lower limit of quantification (LLQ) are included. Pt.1 to Pt.6 received 1 μg/kg IL-13-PE, whereas Pt.7 and Pt.8 received 2 μg/kg IL-13-PE.